Fmoc-Arg(Me)2-OH (symmetrical)
Need Assistance?
  • US & Canada:
    +
  • UK: +

Fmoc-Arg(Me)2-OH (symmetrical)

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
Fmoc-Amino Acids
Catalog number
BAT-015083
CAS number
823780-66-1
Molecular Formula
C23H28N4O4
Molecular Weight
424.50
Fmoc-Arg(Me)2-OH (symmetrical)
IUPAC Name
(2S)-5-[(N,N'-dimethylcarbamimidoyl)amino]-2-(9H-fluoren-9-ylmethoxycarbonylamino)pentanoic acid
Synonyms
Fmoc-SDMA; N2-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N5-[(methylamino)(methylimino)methyl]-L-ornithine; N5-(N,N'-Dimethylcarbamimidoyl)-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-ornithine; (S,E)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(2,3-dimethylguanidino)pentanoic acid; (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-((bis(methylamino)methylene)amino)pentanoic acid
Appearance
White Powder
Purity
≥95%
Density
1.27±0.1 g/cm3
Storage
Store at -20°C
Solubility
Soluble in DMSO
InChI
InChI=1S/C23H28N4O4/c1-24-22(25-2)26-13-7-12-20(21(28)29)27-23(30)31-14-19-17-10-5-3-8-15(17)16-9-4-6-11-18(16)19/h3-6,8-11,19-20H,7,12-14H2,1-2H3,(H,27,30)(H,28,29)(H2,24,25,26)/t20-/m0/s1
InChI Key
DQWCPMLQUQTZMJ-FQEVSTJZSA-N
Canonical SMILES
CNC(=NC)NCCCC(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

Fmoc-Arg(Me)2-OH (symmetrical), a synthetic amino acid derivative, finds widespread use in peptide synthesis and biochemical research. Here are the key applications of Fmoc-Arg(Me)2-OH (symmetrical):

Peptide Synthesis: A staple in solid-phase peptide synthesis, Fmoc-Arg(Me)2-OH (symmetrical) plays a crucial role in incorporating methylated arginine residues into peptides. This modification can significantly alter the binding properties, stability, and biological activity of the peptides. Researchers leverage this technique to delve into protein interactions and engineer therapeutic peptides with heightened efficacy, propelling the boundaries of peptide science.

Epigenetic Research: Delving into the intricate realm of post-translational modifications, symmetrical dimethylation of arginine emerges as a key player in epigenetic regulation. Fmoc-Arg(Me)2-OH (symmetrical) emerges as a foundational building block for synthesizing peptides and proteins employed in unraveling the impact of arginine methylation on gene expression, chromatin structure, and enzyme activity. This deep understanding serves as a linchpin in deciphering the underlying mechanisms of diseases like cancer and neurological disorders, shedding light on their molecular intricacies.

Protein-Protein Interaction Studies: Witness the power of modified arginine residues in sculpting protein-protein interactions as Fmoc-Arg(Me)2-OH (symmetrical) emerges as a potent ally in these explorations. By integrating this derivative into peptides, researchers embark on the journey to decode how arginine methylation shapes binding affinities and interaction networks. This exploration proves particularly pivotal in the realm of drug discovery, where manipulating protein interactions stands as a cornerstone strategy in developing novel therapeutics.

Diagnostic Assay Development: Prepare for a paradigm shift in diagnostic assay development as the integration of Fmoc-Arg(Me)2-OH (symmetrical) into synthetic peptides unlocks a realm of possibilities. These peptides stand at the forefront of creating diagnostic assays, serving as standards or probes in quantifying or detecting specific proteins or antibodies. This application emerges as a cornerstone in fabricating reliable diagnostic tests that find utility in both clinical and research settings.

Online Inquiry
Verification code
Inquiry Basket